McFadden Eve M's Form 4 filing
Sysco Corp (SYY) · filed Dec 5, 2024
- Accession no.
- 0000096021-24-000217
- Filed
- Dec 5, 2024
- Trade date
- Dec 4, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $519.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McFadden Eve MCIK 0001768287 | Officer (SVP, GC & Corp Sec) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2024 | Common Stock | MOption exerciseAcquired | +6,499 | $40.59 | +$263,794.41 | 54,950.16 | Direct | |
| Dec 4, 2024 | Common Stock | SSaleDisposed | −6,499 | $80.00 | −$519,920 | 48,451.16 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2024 | Common Stock | MOption exerciseDisposed | −6,499 | $0.00F3 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2013 Long Term Incentive Plan, as amended.
Referenced by the price of 1 transaction in Table II.